Relationship Between Bone Turnover Markers and Oxidative Stress in Children with Type 1 Diabetes Mellitus

Overview

Journal Pediatr Res

Specialties Biology
Pediatrics

Date 2020 Oct 10

PMID 33038875

Citations 6

Authors

Doaa El Amrousy

Dalia El-Afify

Ahmed Shabana

Affiliations

Soon will be listed here.

Abstract

Background: Oxidative stress in children with type 1 DM (T1DM) may negatively affect the bone.

Methods: This study included 40 children with T1DM as the patient group and 40 healthy children of matched age and sex as the control group. Plasma alkaline phosphatase, procollagen type-1 amino-terminal propeptide (P1NP), and urinary deoxypyridinoline (DPD) were measured to assess bone turnover. Glutathione, superoxide dismutase (SOD), and malondialdehyde (MDA) were measured to assess oxidative stress.

Results: Patients with T1DM had a significantly lower P1NP level but a significantly higher urinary DPD level compared to the control group. Moreover, there were significantly lower glutathione and SOD levels with significantly higher MDA levels in patients with T1DM. We found a significant positive correlation between P1NP level and both glutathione and SOD levels but a significant negative correlation between P1NP and MDA in patients with T1DM. There was a significant negative correlation between DPD levels and both glutathione and SOD levels and a significant positive correlation between DPD and MDA. Moreover, glutathione was a significant predictor for both P1NP and DPD levels, while MDA was a significant predictor for P1NP levels.

Conclusions: There is an association between oxidative stress and bone turnover markers in children with T1DM.

Impact: Oxidative stress can negatively affect bone but the exact relationship between oxidative stress and bone turnover in T1DM has not been previously studied in pediatrics. For the best of our knowledge, our study was the first to assess the relationship between oxidative stress and bone turnover in children with T1DM. We revealed that increased oxidative stress in children and adolescents with T1DM may be involved in the impairment of bone turnover process, so treatment strategies toward better glycemic control and decreasing oxidative stress may be beneficial in preventing and treating diabetic bone disease in these children.

Citing Articles

Challenging directions in pediatric diabetes - the place of oxidative stress and antioxidants in systemic decline.

Lupu V, Miron I, Trandafir L, Jechel E, Starcea I, Ioniuc I Front Pharmacol. 2025; 15:1472670.

PMID: 39744134 PMC: 11688324. DOI: 10.3389/fphar.2024.1472670.

Does metabolic control of the disease related with bone turnover markers in children with type 1 diabetes mellitus in Turkey?.

Topkaya M, Akin O, Comert T BMC Endocr Disord. 2024; 24(1):89.

PMID: 38872156 PMC: 11177411. DOI: 10.1186/s12902-024-01553-0.

Grabia M, Socha K, Soroczynska J, Bossowski A, Markiewicz-Zukowska R Nutrients. 2023; 15(9).

PMID: 37432230 PMC: 10180949. DOI: 10.3390/nu15092084.

Assessment of biochemical bone markers of osteoporosis in children with thalassemia major.

Celik T, Sangun O, Unal S, Balci A, Motor S Ital J Pediatr. 2022; 48(1):105.

PMID: 35725492 PMC: 9210807. DOI: 10.1186/s13052-022-01290-x.

Long-Term Follow-Up of Three Family Members with a Novel Pathogenic Variant Causing Primary Adrenal Insufficiency.

Krasovec T, Sikonja J, Zerjav Tansek M, Debeljak M, Ilovar S, Trebusak Podkrajsek K Genes (Basel). 2022; 13(5).

PMID: 35627102 PMC: 9140979. DOI: 10.3390/genes13050717.

References

Weber D, Schwartz G . Epidemiology of Skeletal Health in Type 1 Diabetes. Curr Osteoporos Rep. 2016; 14(6):327-336. PMC: 5130154. DOI: 10.1007/s11914-016-0333-0. View

Weber D, Haynes K, Leonard M, Willi S, Denburg M . Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN). Diabetes Care. 2015; 38(10):1913-20. PMC: 4580610. DOI: 10.2337/dc15-0783. View

Franceschi R, Longhi S, Cauvin V, Fassio A, Gallo G, Lupi F . Bone Geometry, Quality, and Bone Markers in Children with Type 1 Diabetes Mellitus. Calcif Tissue Int. 2018; 102(6):657-665. DOI: 10.1007/s00223-017-0381-1. View

Garnero P . Bone markers in osteoporosis. Curr Osteoporos Rep. 2009; 7(3):84-90. DOI: 10.1007/s11914-009-0014-3. View

Amin S, El Amrousy D, Elrifaey S, Gamal R, Hodeib H . Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease. J Pediatr Gastroenterol Nutr. 2017; 66(1):117-121. DOI: 10.1097/MPG.0000000000001768. View

El Amrousy D, El-Afify D . Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease. Cytokine. 2020; 135:155215. DOI: 10.1016/j.cyto.2020.155215. View

Seibel M . Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2006; 26(4):97-122. PMC: 1320175. View

Tanaka H, Hamano T, Fujii N, Tomida K, Matsui I, Mikami S . The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone. 2009; 45(5):949-55. DOI: 10.1016/j.bone.2009.07.016. View

Al-Hariri M . Sweet Bones: The Pathogenesis of Bone Alteration in Diabetes. J Diabetes Res. 2016; 2016:6969040. PMC: 5061963. DOI: 10.1155/2016/6969040. View

10.

Hamada Y, Fujii H, Kitazawa R, Yodoi J, Kitazawa S, Fukagawa M . Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications. Bone. 2009; 44(5):936-41. DOI: 10.1016/j.bone.2008.12.011. View

11.

Giacco F, Brownlee M . Oxidative stress and diabetic complications. Circ Res. 2010; 107(9):1058-70. PMC: 2996922. DOI: 10.1161/CIRCRESAHA.110.223545. View

12.

Chavan S, Sava L, Saxena V, Pillai S, Sontakke A, Ingole D . Reduced glutathione: Importance of specimen collection. Indian J Clin Biochem. 2012; 20(1):150-2. PMC: 3454161. DOI: 10.1007/BF02893062. View

13.

Hygum K, Starup-Linde J, Harslof T, Vestergaard P, Langdahl B . MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol. 2017; 176(3):R137-R157. DOI: 10.1530/EJE-16-0652. View

14.

Starup-Linde J, Eriksen S, Lykkeboe S, Handberg A, Vestergaard P . Biochemical markers of bone turnover in diabetes patients--a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int. 2014; 25(6):1697-708. DOI: 10.1007/s00198-014-2676-7. View

15.

Safarova S . Alterations of Bone Metabolism in Patients with Diabetes Mellitus. Int J Endocrinol. 2020; 2019:5984681. PMC: 6942853. DOI: 10.1155/2019/5984681. View

16.

Elhabashy S, Said O, Agaiby M, Abdelrazek A, Abdelhamid S . Effect of physical exercise on bone density and remodeling in egyptian type 1 diabetic osteopenic adolescents. Diabetol Metab Syndr. 2011; 3:25. PMC: 3206406. DOI: 10.1186/1758-5996-3-25. View

17.

Keenan H, Maddaloni E . Bone Microarchitecture in Type 1 Diabetes: It Is Complicated. Curr Osteoporos Rep. 2016; 14(6):351-358. PMC: 5106327. DOI: 10.1007/s11914-016-0338-8. View

18.

Neve A, Corrado A, Cantatore F . Osteoblast physiology in normal and pathological conditions. Cell Tissue Res. 2010; 343(2):289-302. DOI: 10.1007/s00441-010-1086-1. View

19.

Joshi A, Varthakavi P, Chadha M, Bhagwat N . A study of bone mineral density and its determinants in type 1 diabetes mellitus. J Osteoporos. 2013; 2013:397814. PMC: 3628496. DOI: 10.1155/2013/397814. View

20.

Miazgowski T, Czekalski S . A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus. Osteoporos Int. 1998; 8(5):399-403. DOI: 10.1007/s001980050082. View